C50.9
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: postmeopausal women with breast cancer in stage I-III (TNM: T1-4 N0-3 M0), Hormon receptor positiv,undergoing aromatase Inhibitor therapy, 50-79 years old, Minimum distance of time to last chemotherapy or radiotherapy 3 months
Exclusion criteria
Exclusion criteria: mental disorders Treatment with corticosteroids metastasis distance of time to chemotherapy < 3 months distance of time to radiotherapy < 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| monthly Evaluation of cortisol and prolactin blood levels. Cortisol and prolactin levels are analysed in the afternoon. Evaluation period: 6 months (T1 - T 6). | — |
Secondary
| Measure | Time frame |
|---|---|
| monthly assessment of Quality of Life by using the questionnaires of the EORTC-Quality-of-Life-Research-Group: QLQ-C30 Version 3.0 and QLQ-BR23). | — |
Countries
Germany
Contacts
Rehaklinik Ahrenshoop (seit 01.01.2019)